Advertisement
Loading...

Transcenta Holding Limited

6628.HKHKSE
Healthcare
Biotechnology
HK$1.60
HK$0.02(1.27%)
Hong Kong Market is Open • 10:33
Advertisement

Transcenta Holding Limited (6628.HK) Stock Competitors & Peer Comparison

See (6628.HK) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
6628.HKHK$1.47-2.65%673.4M-2.77-HK$0.57N/A
6160.HKHK$169.90-2.97%238.5B66.72HK$2.65N/A
1801.HKHK$80.60+7.68%144.6B154.35HK$0.54N/A
2269.HKHK$34.22+5.68%137.8B24.88HK$1.34N/A
9926.HKHK$119.20+7.97%108.6B-83.76-HK$1.41N/A
6990.HKHK$439.80-1.61%107.7B-243.16-HK$1.90N/A
1177.HKHK$5.00+3.95%89.2B33.27HK$0.15+1.80%
3759.HKHK$17.22-0.98%47.8B15.93HK$1.10+1.25%
1530.HKHK$18.60+7.83%46.3B4.67HK$3.96+1.35%
9995.HKHK$78.95+0.00%45.7B55.47HK$1.49N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

6628.HK vs 6160.HK Comparison June 2026

6628.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 6628.HK stands at 673.4M. In comparison, 6160.HK has a market cap of 238.5B. Regarding current trading prices, 6628.HK is priced at HK$1.47, while 6160.HK trades at HK$169.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

6628.HK currently has a P/E ratio of -2.77, whereas 6160.HK's P/E ratio is 66.72. In terms of profitability, 6628.HK's ROE is -0.28%, compared to 6160.HK's ROE of +0.12%. Regarding short-term risk, 6628.HK is more volatile compared to 6160.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 6628.HK.Check 6160.HK's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions